✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
圣和化工
首页 › 产品目录 › 塞瑞替尼

塞瑞替尼

CAS 1032900-25-6C28H36ClN5O3SMW 558.1

塞瑞替尼,CAS 登记号 1032900-25-6,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于医药中间体及原料药。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号1032900-25-6
分子式C28H36ClN5O3S
分子量558.1
LogP6.4
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域医药中间体及原料药
类别医药中间体及原料药

用途与场景

医药中间体及原料药

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 塞瑞替尼 的 CAS 号?

本页已列出 塞瑞替尼 的 CAS 号:1032900-25-6,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

塞瑞替尼 一般用在什么产品里?

主要涉及医药中间体及原料药。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

Ceritinib · CAS 1032900-25-6 · C28H36ClN5O3S. UNII K418KG2GET.

Identification

CAS Registry Number1032900-25-6
PubChem CID57379345
Molecular formulaC28H36ClN5O3S
IUPAC name5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine
UNII (FDA)K418KG2GET

Computed Descriptors

Molecular Weight558.1
XLogP36.4
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count8
Rotatable Bond Count9
Exact Mass557.2227389
Monoisotopic Mass557.2227389
Topological Polar Surface Area114
Heavy Atom Count38
Formal Charge0

Physical description & handling notes

  • 9.7 and 4.1

GHS Hazard Classification

Reported hazard statementsH302 (33.3%), H360 (16.7%), H372 (66.7%), H400 (16.7%), H410 (66.7%)

H302 (33.3%): Harmful if swallowed [Warning Acute toxicity, oral]

H360 (16.7%): May damage fertility or the unborn child [Danger Reproductive toxicity]

Documented Uses

  • Ceritinib is a small molecule tyrosine kinase receptor inhibitor and antineoplastic agent that is used in the therapy of selected forms of advanced non-small cell lung cancer (NSCLC). Ceritinib is associated with a moderate rate of serum aminotransferase elevations during therapy and rare instances of clinically apparent acute liver injury.
  • Breast Feeding; Lactation; Milk, Human; Antineoplastic Agents; Enzyme Inhibitors; Protein Kinase Inhibitors; Signal Transduction Inhibitors; Tyrosine Kinase Inhibitors
  • Ceritinib is approved to treat:
  • • Non-small cell lung cancer that is ALK positive and has metastasized (spread to other parts of the body). It is used in adults.
  • Ceritinib is also being studied in the treatment of other types of cancer.
  • Avoid grapefruit products. Grapefruit inhibits the CYP3A metabolism of ceritinib, which may increase its serum concentration.

Synonyms

ceritinib; 1032900-25-6; LDK378; ZYKADIA; LDK-378; NVP-LDK378-NX; LDK 378; K418KG2GET; ceritinibum; NVP-LDK-378-NX; CHEBI:78432; DTXSID10725373; RefChem:57924; DTXCID50676118; L01XE28; 811-457-8

Frequently Asked Questions

What are the CAS number and molecular formula of Ceritinib?

CAS 1032900-25-6; molecular formula C28H36ClN5O3S; molecular weight — g/mol.

What other names is Ceritinib known by?

ceritinib, 1032900-25-6, LDK378, ZYKADIA, LDK-378, NVP-LDK378-NX.

Is Ceritinib classified as hazardous?

Hazard statements reported: H302, H360, H372, H400, H410.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 塞瑞替尼 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1